Studies related to Acne and Chromium

The Effects Of Chromium Supplementation On Endocrine Profiles, Biomarkers Of Inflammation, And Oxidative Stress In Women With Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial

Effect Decrease
Values 20% prevalence in placebo group vs. 3.3% in chromium group after 8 weeks.
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 60
Sex Female
Age Range 18-29, 30-44
Notes for this study:
60 woman with PCOS were given either placebo or 200 µg chromium picolinate for 8 weeks. Chromium reduced acne, hirsutism, and C-reactive protein and improved plasma total antioxidant capacity but no change in reproductive hormones (FSH, LH, prolactin, and free testosterone).